DermTech

DMTK48

$55.650.00%$0.00

DMTK48

$55.65

0.00%$0.00

Performance History

Key Stats
Open	$55.65
Prev. Close	$55.65
EPS	-2.65
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	55.65	55.65
52 Week Range	55.65	55.65

Ratios







EPS	-2.65

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About DermTech (DMTK)

DermTech Inc. (DMTK) is a company that specializes in non-invasive, precision dermatology. Their mission is to transform the way skin diseases are diagnosed and treated by leveraging genomics and digital technology. The company has developed a unique molecular dermatology platform called DermTech PLA that allows for the early detection of skin cancer and other skin diseases.

DermTech Inc. was founded in 1996 and is headquartered in La Jolla, California. The company's stock is publicly traded on the Nasdaq Global Market under the ticker symbol DMTK. As of [date], the stock price for DMTK is $[price].

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Mr. Bret Christensen
Headquarters: San Diego
Employees: 278
Exchange: NASDAQ

Keep an eye on DermTech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is DermTech 's (DMTK) price per share?

The current price per share for DermTech (DMTK) is $55.65. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for DermTech (DMTK)?

For DermTech (DMTK), the 52-week high is $55.65, which is 0% from the current price. The 52-week low is $55.65, the current price is 0% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is DermTech (DMTK) a growth stock?

DermTech (DMTK) has shown an average price growth of -7.23% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying DermTech as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is DermTech (DMTK) stock price performance year to date (YTD)?

As of the latest data, DermTech (DMTK) has a year-to-date price change of 3.25K%. Over the past six months, the figure is 15.58K%. Looking at a longer horizon, the five-year price change stands at 618.06%.

help

Is DermTech (DMTK) a profitable company?

DermTech (DMTK) has a net income of -$100.89M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 1.8% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -533.37% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $15.3M, with a revenue growth rate of 5.36%, providing insight into the company's sales performance and growth. The gross profit is $276K. Operating income is noted at -$103.74M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of DermTech (DMTK)?

DermTech (DMTK) has a market capitalization of $1.95B. The average daily trading volume is 0, indicating the stock's liquidity and investor engagement.